SUMMARY -Th e aim of this study was to investigate the controversial infl uence of anthropometry on clinical severity and prognosis of acute ST-elevation myocardial infarction (STEMI). We prospectively analyzed 250 patients with acute STEMI treated with primary percutaneous coronary intervention (September 2011 -September 2012. Th ey were grouped according to the following anthropometric parameters: body mass index (BMI) (<25.0, 25.0-29.9, ≥30.0 kg/m²), waist circumference (WC) (<102/88, ≥102/88 cm), waist-to-hip ratio (WHR) (<0.90/0.85, ≥0.90/0.85) and waistto-height ratio (WHtR) (<53/49, 53/49-62/57, ≥63/58). Th e groups were analyzed by baseline, as well as severity (clinical, laboratory, echocardiography, coronary angiography, in-hospital complications) and prognostic parameters (major adverse cardiovascular events and sick leave duration during 12-month follow up). Patients with BMI <25.0 kg/m 2 had the highest rates of dyspnea and those with BMI ≥30.0 kg/m² had the longest hospitalization and widest stents; patients with WHR ≥0.90/0.85 had higher rates of signifi cantly stenosed proximal/middle coronary segments, while those with WHtR ≥63/58 had the highest rates of heart failure and total in-hospital complications (p<0.05). BMI <25.0 kg/m 2 increased (odds ratio (OR) 2.00, confi dence interval (CI) [1.09-3.68], p=0.026) and BMI 25.0-29.9 kg/m 2 reduced (OR 0.52, CI [0.30-0.91], p=0.022) the risk of dyspnea; WHR ≥0.90/0.85 increased the risk of signifi cant proximal/middle coronary segment stenosis (OR 3.34,.86], p=0.029) and WHtR ≥63/58 the risk of heart failure (OR 2.05, CI [1.13-3.71], p=0.017) and total in-hospital complications (OR 1.94,], p=0.017) (p<0.05). In conclusion, WHR and WHtR are better anthropometric parameters than BMI in predicting acute STEMI severity, while WC has no infl uence on it. Anthropometry has no infl uence on prognosis.
Introduction
Overweight and obesity are one of the major public health problems. Worldwide, at least 1.4 billion adults are overweight, i.e. over 200 million men and nearly 300 million women are obese 1 . Obesity prevalence in Europe has reached epidemic proportions (up to 28.3% of men and 36.5% of women) with higher prevalence rates in Central, Eastern, and Southern Europe than those in Western and Northern Europe 2 . Obesity is an independent risk factor for the development of cardiovascular disease (CVD), including coronary artery disease (CAD) and heart failure. It is frequently associated with other CVD risk factors such as arterial hypertension, diabetes mellitus type 2, atherogenic dyslipidemia, as well as with an increased risk of allcause morbidity and mortality 3 . Measurement of body mass index (BMI), waist circumference (WC), waistto-hip ratio (WHR) and waist-to-height ratio (WHtR) is a primary method for diagnosing obesity. While BMI determines overall obesity, other anthropometric parameters are related to central obesity where body fat is primarily located in the abdomen. Central obesity measures, especially WHtR, are stronger predictors of CVD risk than BMI 4, 5 . Central obesity correlates with excessive visceral fat, which is directly associated with insulin resistance and compensatory hyperinsulinemia, dyslipidemia and infl ammatory states that synergistically lead to smooth muscle cell proliferation, calcium and cholesterol ester deposition in the artery, and fi nally to atherosclerotic vascular disease 6 . In subjects with acute myocardial infarction (MI), there is positive association of abdominal obesity and decreasing BMI with higher mortality. Th is has been called the 'obesity paradox'. Th e possible explanation could be that BMI does not adequately discriminate the diff erence between body fat (especially abdominal) and lean muscle mass 4 . Using the anthropometric parameters, the aims of this study were:
1. to evaluate the baseline data of patients with obesity and acute ST-elevation myocardial infarction (STEMI), and to compare the results with STEMI patients without obesity; 2. to evaluate the severity and prognosis of acute STEMI in patients with obesity, and to compare the results with STEMI patients without obesity; and 3. to investigate the controversial infl uence of anthropometric parameters on clinical severity and prognosis of acute STEMI, as well as their unknown infl uence on the involvement of coronary artery segments with signifi cant stenosis and sick leave duration (SLD).
Patients and Methods

Patient population
Th is prospective monocentric study was performed on 250 consecutive patients with acute STEMI. Th ey were treated with primary percutaneous coronary intervention (PCI) at Department of Cardiology, Sestre milosrdnice University Hospital Center (September 2011 -September 2012). Th e diagnosis was established and primary PCI performed using the criteria of the European Society of Cardiology 7, 8 . Th e inclusion criteria were presenting within 12 h from the onset of symptoms (history of chest pain/discomfort lasting for 10-20 minutes or more, not responding fully to nitroglycerine), persistent ST-segment elevation on electrocardiography in at least two consecutive leads, or (presumed) new left bundle-branch block, and elevated cardiac laboratory biomarkers (cardiac troponin T (cTnT) and creatine kinase (CK)). Th e study was approved by the Ethics Committee of the Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Data collection
After primary PCI, patients were grouped according to anthropometric parameters as follows: BMI (<25.0, 25.0-29.9 and ≥30.0 kg/m² for normal weight, overweight and overall obesity, respectively), WC (<102/88 and ≥102/88 cm for normal weight and central obesity in males/females, respectively), WHR (<0.90/0.85 and ≥0.90/0.85 for normal weight and central obesity in males/females, respectively) and WHtR (<53/49, 53/49-62/57 and ≥63/58 for normal weight, overweight and central obesity in males/females, respectively) 4, 9 . Th e groups were analyzed by baseline, as well as severity and prognostic parameters of acute STEMI.
Baseline parameters
Baseline demographic and medical history parameters included gender, age, arterial hypertension, dyslipidemia (elevated triglycerides and/or low HDLcholesterol), hyperglycemia, smoking status, known family history of cardiovascular events (MI, cerebrovascular insult), previous MI, previous PCI and coronary artery bypass grafting (CABG).
For the diagnosis of dyslipidemia, hypertension and hyperglycemia, we used the criteria published by the National Cholesterol Education 
Severity parameters
Th e severity of acute STEMI was estimated by clinical presentation (angina pectoris, dyspnea, and length of hospitalization), in-hospital complications (arrhythmias, conduction disturbances, reperfusion arrhythmias, heart failure, cardiogenic shock, cardiac arrest, mechanical ventilation, reinfarction, repeated PCI, mortality, and total in-hospital complications), laboratory (maximal cTnT, CK), echocardiography (left ventricular ejection fraction, LVEF) and coronary angiography fi ndings.
Serum CK activity was measured by spectrophotometry (Olympus 680, Beckman Coulter Inc., California, USA). Serum cTnT levels were measured by electrochemiluminescence (ECL) assay (Cobas e411, Roche Diagnostics, Sussex, UK). During hospital stay, echocardiography (Acuson Sequoia 512, Siemens, Munich, Germany) was performed in all patients according to the clinical standards and current echocardiography guidelines 10 . Coronary angiography was performed by applying a monoplane system (Axiom Artis, Siemens, Erlangen, Germany) by a common technique, as recommended in current guidelines 8 . Patients received 70 IE/kg unfractionated heparin, 300 mg aspirin, a loading dose of 600 mg clopidogrel, and a GPIIb/IIIa inhibitor according to judgment of interventional cardiologist. Coronary artery stenosis of more than 50% was considered clinically signifi cant. We analyzed the number of signifi cantly narrowed coronary arteries, and number, length and diameter of stents used. Additionally, for the fi rst time, we analyzed signifi cantly stenosed segments of coronary arteries. For that purpose, and according to the modifi ed American Heart Association classifi cation 11 , coronary arteries were divided into 16 segments. Segments were classifi ed in two groups, as follows:
1. proximal and middle coronary segments: segment 1 (right coronary artery (RCA), proximal), segment 2 (RCA, mid), segment 5 (main stem), segment 6 (left anterior descending coronary artery (LAD), proximal), segment 7 (LAD, mid), segment 9 (fi rst diagonal), segment 11 (left circumfl ex artery (LCX), proximal), segment 12 (obtuse marginal); and 2. distal coronary segments: segment 3 (RCA, distal), segment 4 (right posterior descendens), segment 8 (LAD, distal), segment 10 (second diagonal), segment 13 (LCX, distal), segment 14 (LCX, posterolateral branch), segment 15 (LCX, posterodescendens branch), segment 16 (RCA, posterolateral branch).
Prognostic parameters
Th e prognosis of acute STEMI was estimated using major adverse cardiovascular events (MACE) parameters (reinfarction, coronary artery restenosis and/ or new stenosis, cardiac and non-cardiac rehospitalization, cerebrovascular insult, urgent CABG, mortality, total MACE) during 12-month follow up. Data were collected by medical examination, checking medical documentation, or telephone contact with patients, family members or home physicians. In addition, during the same follow up period, we collected data on SLD of working population.
Statistical analysis
Qualitative data were expressed as absolute number and percentage. We used c 2 -test with Yates correction for comparison and analysis. Quantitative data were expressed as median and corresponding interquartile range. Diff erences between two groups were tested by Mann-Whitney U test. Diff erences among three groups were tested by nonparametric analysis of variance (Kruskal-Wallis ANOVA). Logistic regression analysis was used to investigate the relationship between one dependent and one or more independent variables that may infl uence or predict the value of the dependent variable. Th e limit of statistical signifi cance was set at p<0.05. Processing was done using the STA-TISTICA 6.0 for Windows software.
Results
Among 250 patients, there were 72 (28.8%) patients with BMI ≥30.0 kg/m², 149 (59.6%) with WC ≥102/88 cm, 222 (88.8%) with WHR ≥0.90/0.85 and 81 (32.4%) with WHtR ≥63/58. We recorded the following results:
1) BMIs ≥30.0 kg/m² had the highest rates of hypertension and dyslipidemia, the longest hospitalization and widest stents, while BMIs <25.0 kg/m 2 had the highest rates of dyspnea (p<0.05). Other baseline and parameters of severity, as well as all prognostic parameters were without signifi cant diff erences (Tables 1  and 2) .
2) WCs ≥102/88 cm were more frequently recorded in males and were associated with higher rates of hypertension (p<0.05). Other baseline, as well as all severity and prognostic parameters were without signifi cant diff erences (Tables 1 and 2). 3) WHRs ≥0.90/0.85 were more frequently found in males and were associated with higher rates of dyslipidemia and signifi cantly stenosed proximal/middle coronary artery segments (p<0.05). Other baseline and parameters of severity, as well as all prognostic parameters were without signifi cant diff erences (Tables 3 and 4). 4) WHtRs ≥63/58 were more frequently found in females and were associated with the highest rates of arterial hypertension, heart failure and total in-hospital complications (p<0.05). Other baseline and parameters of severity, as well as all prognostic parameters were without signifi cant diff erences (Tables 3 and 4 
Discussion
Th e main objective of this study was to investigate the controversial infl uence of anthropometric parameters on clinical severity and prognosis of acute STE-MI, as well as their unknown infl uence on the involvement of coronary segments with signifi cant stenosis and SLD.
We found the measures of central obesity (WHR and WHtR) to be superior to BMI in predicting clinical severity (signifi cant proximal/middle coronary segment stenosis, heart failure and total in-hospital complications vs. dyspnea), while WC had no infl uence on it. Also, anthropometric parameters had no infl uence on prognosis. Finally, the number of signifi cantly ste- 
Mortality, n (%) 6 (10) BMI = body mass index; CABG = coronary artery bypass graft; CA = coronary artery; CK = creatinine phosphokinase; cTnT = cardiac troponin T; CVI = cerebrovascular insult; ECHO = echocardiography; MACE = major adverse cardiovascular events; PCI = percutaneous coronary intervention; WC = waist circumference nosed coronary arteries increased the risk of total MACE, which is consistent with literature data 12 . Several studies have reported a paradoxical clinical eff ect of elevated BMI on improved survival after primary PCI in patients with acute STEMI, i.e. the overall 'obesity paradox'. Overweight and obese patients had wider stents, normal LVEF, lower CK levels, inhospital and overall mortalities, as well as lower rates of MACE during 12-month follow up [13] [14] [15] [16] . According to other authors, obese patients with acute STEMI had similar PCI characteristics and MACE as normal weights and overweights 17 . Iakobishvili et al. and Li et al. found no signifi cant diff erences in infarct size, and in 3-month and 1-year outcomes among the BMI categories with acute STEMI and primary PCI 18, 19 . Th e 'obesity paradox' could explain why we found no signifi cant diff erences among normal weight, overweight and overall obese patients in prognosis, as well as that of the severity parameters, normal weight increased and overweight reduced the risk of dyspnea.
Th e presence of increased WC is associated with greater myocardial necrosis in patients with acute MI 20 . However, it has been reported that increased WC has a protective role for the presence of significant angiographic CAD, i.e. central 'obesity paradox' 21 . Subcutaneous fat component is probably mainly responsible for the paradoxical protective eff ect of central obesity, whereas visceral fat may have an opposing eff ect and increase the risk of signifi cant angiographic CAD. WC does not add prognostic information for predicting six-month mortality or myocardial reinfarction in patients with acute MI 22 . In this study, we found no signifi cant diff erences in any of the parameters of severity and prognosis between patients with normal and increased WC.
Th e presence of increased WHR is associated with signifi cant coronary stenosis, but not with the number of signifi cantly stenosed coronary arteries 23 . In acute STEMI, patients with increased WHR more frequently have heart failure and WHR ≥0.90/0.85 is an independent predictor of six-month mortality 24 . In our study, where a small number of patients with normal WHR was found as expected, the presence of increased WHR was associated with signifi cant stenosis of proximal/middle coronary segments, but without signifi cant diff erences in other severity and in all prognostic parameters.
Of the anthropometric parameters, WHtR yielded the highest positive correlation with CAD 25 . Th is was the fi rst study on the eff ect of WHtR on clinical severity and prognosis of acute STEMI. We found that WHtR ≥63/58 increased the risk of heart failure and total in-hospital complications. Considering the small 
Mortality, n (%) 5 (11.9) 9 (7. CABG = coronary artery bypass graft; CA = coronary artery; CK = creatinine phosphokinase; cTnT = cardiac troponin T; CVI = cerebrovascular insult; ECHO = echocardiography; MACE = major adverse cardiovascular events; PCI = percutaneous coronary intervention; WHR = waist-to-hip ratio; WHtR = waist-to-height ratio number of patients with normal WHR and WHtR values as the main limitation of this study, investigation with a greater number of patients should be performed to confi rm these results.
Conclusion
In conclusion, WHR and WHtR are better anthropometric parameters than BMI in predicting acute STEMI severity, while WC has no infl uence on it. Anthropometry has no infl uence on prognosis.
